PRKCA and malignant glioma: Trametinib effectively blocked the colony formation of immortalized human astrocytes expressing D463H mutant PRKCA, while causing only a mild reduction in colony formation for the malignant glioma cell lines with wild-type PRKCA alleles (Fig. 4).